Showing results (161-170 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|August 1, 1993
Exacerbation of focal seizures due to carbamazepine treatment in an adult patientM Y NeufeldClinical Neuropharmacology|February 1, 1993
Short-term beneficial effect of deprenyl monotherapy in early Parkinson's disease: a quantitative assessmentI Ziv, A Achiron, R Djaldetti, et al.Clinical Neuropharmacology|February 1, 1993
Effects of selegiline dosing on motor fluctuations in Parkinson's diseaseJ P Hubble, W C Koller, C WatersClinical Neuropharmacology|April 1, 1993
Pharmacological basis of immunotherapy in autoimmune diseasesB Rouveix, O BlinClinical Neuropharmacology|April 1, 1993
Response to L-DOPA in multiple system atrophyE A Parati, V Fetoni, G C Geminiani, et al.Clinical Neuropharmacology|April 1, 1993
Relation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's diseaseF Durif, M Paire, D Deffond, et al.Clinical Neuropharmacology|April 1, 1993
A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndromeR Kurlan, P G Como, C Deeley, et al.Clinical Neuropharmacology|February 1, 1997
Effects of pregnancy on various pathways of human antiepileptic drug metabolismI Bernus, W D Hooper, R G Dickinson, et al.Clinical Neuropharmacology|February 1, 1997
Quantitative electromyography-guided botulinum toxin treatment of cervical dystoniaJ Finsterer, I Fuchs, B MamoliClinical Neuropharmacology|February 1, 1997
Neurobehavioral syndrome induced by H2-receptor blocker withdrawal: possible role of prolactinL Rampello, R Raffaele, G Nicoletti, et al.Pageof 236